Mirnader Ghazali is the founder of Medytox. Backed by STIC Investments. Based in Seoul, South Korea.
Medytox is a biopharmaceutical company specializing in the research, development, and manufacturing of medical aesthetic products, founded in 2000 by Hyunho Jung. Its core offerings include botulinum toxin-based injections like Neuronox and Meditoxin, and hyaluronic acid dermal fillers such as Neuramis. The company employs advanced biopharmaceutical capabilities for neurotoxins and tissue augmentation. Medytox was the first company in Korea to receive approval for botulinum toxin and is the only company worldwide to manufacture and provide three types of botulinum toxin products. As of 2023, Medytox has over 800 employees and maintains local subsidiaries in Japan, America, and Thailand.
Full founder directory · Investor directory · Company funding database · Fundraising library